HomeMAZE • NASDAQ
add
Maze Therapeutics Inc
Previous close
$7.70
Day range
$7.16 - $8.34
Year range
$6.72 - $17.00
Market cap
359.57M USD
Avg Volume
291.83K
P/E ratio
105.55
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | — |
Operating expense | 29.73M | 28.96% |
Net income | -29.58M | -11.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -29.02M | -31.47% |
Effective tax rate | 0.92% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 196.81M | 574.98% |
Total assets | 240.54M | 236.40% |
Total liabilities | 43.64M | -28.99% |
Total equity | 196.90M | — |
Shares outstanding | 43.80M | — |
Price to book | -0.06 | — |
Return on assets | -34.32% | — |
Return on capital | -36.97% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -29.58M | -11.30% |
Cash from operations | -22.45M | -8.76% |
Cash from investing | -605.00K | -1,679.41% |
Cash from financing | 70.26M | 334.04% |
Net change in cash | 47.20M | 1,151.57% |
Free cash flow | -13.03M | — |
About
Founded
2017
Headquarters
Website
Employees
125
